Combination Nasal Spray Demonstrates Results in Treating Children with Seasonal Allergic Rhinitis
May 8th 2019Positive results were collected from a Phase 3 study of an investigational fixed-dose combination nasal spray for the treatment of seasonal allergic rhinitis (SAR), according to Glenmark Pharmaceuticals.
Read More
Combination Drug for Adults with T2D is Granted FDA Approval
May 6th 2019Dapagliflozin is a selective sodium‑glucose cotransporter-2 (SGLT-2) inhibitor that is combined with a dipeptidyl peptidase‑4 (DPP‑4) inhibitor, saxagliptin; and metformin hydrochloride extended release.
Read More